HomePTGX • NASDAQ
add
Protagonist Therapeutics Inc
Previous close
$55.95
Day range
$54.12 - $60.11
Year range
$24.22 - $60.11
Market cap
3.58B USD
Avg Volume
967.70K
P/E ratio
14.20
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Revenue | 170.64M | 184.40% |
Operating expense | 43.86M | 18.69% |
Net income | 131.67M | 381.70% |
Net profit margin | 77.17 | 69.38% |
Earnings per share | 1.98 | 350.00% |
EBITDA | 126.90M | 444.70% |
Effective tax rate | 1.49% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 418.91M | 22.63% |
Total assets | 744.72M | 108.05% |
Total liabilities | 69.43M | 226.36% |
Total equity | 675.30M | — |
Shares outstanding | 61.38M | — |
Price to book | 5.06 | — |
Return on assets | 47.00% | — |
Return on capital | 51.58% | — |
Cash Flow
Net change in cash
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Net income | 131.67M | 381.70% |
Cash from operations | -29.18M | -272.04% |
Cash from investing | -8.72M | 85.76% |
Cash from financing | 4.03M | 664.90% |
Net change in cash | -33.87M | 22.67% |
Free cash flow | -73.77M | -1,317.58% |
About
Founded
2006
Headquarters
Website
Employees
126